(19)
(11) EP 3 687 540 A1

(12)

(43) Date of publication:
05.08.2020 Bulletin 2020/32

(21) Application number: 18859565.6

(22) Date of filing: 24.09.2018
(51) International Patent Classification (IPC): 
A61K 31/444(2006.01)
A61P 11/00(2006.01)
 C07D 401/14(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2018/052503
(87) International publication number:
WO 2019/060860 (28.03.2019 Gazette 2019/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.09.2017 CN 201710875041
28.03.2018 CN 201810265417
02.07.2018 CN 201810710340
05.09.2018 CN 201811034891

(71) Applicant: CGeneTech (Suzhou, China) Co., Ltd.
Suzhou, Jiangsu 215123 (CN)

(72) Inventors:
  • ZHANG, Xiaohu
    Jiangsu 215028 (CN)
  • ZHENG, Jiyue
    Jiangsu 215123 (CN)
  • MA, Haikuo
    Jiangsu 215123 (CN)

(74) Representative: Weickmann & Weickmann PartmbB 
Postfach 860 820
81635 München
81635 München (DE)

   


(54) HETEROARYL COMPOUNDS AS CXCR4 INHIBITORS, COMPOSITION AND METHOD USING THE SAME